TBS iNsight™ serves as a foundation technology for tissue structure assessment software applications.
Leveraged first in the field of osteoporosis as the gold standard for bone microarchitecture assessment on DXA in osteoporosis: such as, making a difference in patient lives.
This software is used in daily clinical routine in osteoporosis, to better predict fracture risk. In fact, ongoing research shows its applicability in other medical fields.
Medimaps Group has been certified by BSI to ISO 13485:2016 under certificate number MDR 799726. TBS iNsight is a trademark of Medimaps Group. TBS iNsightTM is cleared for sale in the U.S.